December 20, 2023 Sophia Vida
Breaking News

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

–Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”) a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity. Based in Pittsburgh, PA, the Company has made substantial strides over the past year, achieving critical … Continue reading “Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished”